@TekCyte is very excited by Cynata's (@cynatastemcells) interim results. We hope that one day our combined technologies can help reduce the impact of diabetic foot ulcers (DFU) on the quality of life of diabetes sufferers. #diabetes, #chronicwounds, #stemcells
We have conducted an initial analysis of wound surface area in our Phase 1 clinical trial of CYP-006TK for diabetic foot ulcers, with promising results. Read about it here: https://t.co/OhsDiA4CE2 #stemcells#diabetes#ClinicalTrials
JOIN US online to hear an update from the 3 outstanding #youngscientists CureCell has supported this year at our inaugural Annual Showcase on 22 Nov 2pm AEST
+ we'll tell you about CureCell's ambitious plans for 2023 🙂
Register for our free event: https://t.co/kFMSTeNzuR
We are extremely pleased to announce that we have raised $7.5 million at first close of our current funding round, welcoming on board new venture capital business Tenmile as the cornerstone investor together with strong support from existing investors.
https://t.co/ZwzbysK8Og
Cynata is excited to announce that we have received a notice of allowance from the United States Patent and Trademark Office. This notice is for the patent application covering the use of MSCs in the treatment of asthma and allergic airways disease.
https://t.co/Z8zW4TjcMR
CYP-006TK in Adults With Diabetic Foot Ulcers utilizing @TekCyte's heptylamine plasma polymer-coated silicone dressing is currently recruiting 30 patients in a P1 trial. W primary & secondary outcomes being 24 weeks, but still further trials needed. https://t.co/zD0TXDSjmZ
Cynata’s Cymerus™ mesenchymal stem cells (MSCs) were used in an independent and very successful study conducted by the Cooperative Research Centre for Cell Therapy Manufacturing (CTM CRC) in a preclinical model of diabetic wounds https://t.co/NFm1R40Fgq
Our Chair, Leanna Read has been honoured by the @UniofAdelaide with the honorary degree of Doctor of the University.
Well done, Leanna and so well deserved for your tireless efforts in research, government and the biotech industry in SA and Australia.
How cool is this? Out of this world! @UniversitySA scientists @ScienceByDRE and @RoyaRudd are partnering with @EnergyPhos to build units which can remotely power devices in #space for decades without a fuel source. @UniSAFII https://t.co/SBgGDO9k29
Cynata’s Cymerus™ #mesenchymalstemcells (MSCs) were found to be highly effective in an independent study in a preclinical model of #diabeticwounds.
Read more: https://t.co/KCl1FT9kgy
Congratulations @AllisonCowin . What great news!. @TekCyte is certainly looking forward to our ongoing relationship and future successes working with FII.
Congratulations on your new role @AllisonCowin! 👏🏼👏🏼 Outstanding news!
Your leadership will help guide @UniSAFII to great outcomes and a strong future @UniversitySA
Congratulation to @cynatastemcells on commencing the DFU trial. @TekCyte is pleased to be a partner on the first clinical trial to treat this chronic condition.
Commencing the first human trial is a major milestone in the development of any new product, and we are pleased to have achieved this for our diabetic foot ulcers (DFU) program prior to the end of the year as projected.
Read more: https://t.co/W91gEjPRpU
Leanna’s tireless efforts serving the Australian Biotech industry is an inspiration for as all. We at @TekCyte and @Carina are very fortunate to be drawing on her expertise and guidance.
Along with our friends at @TekCyte, we send our congratulations to our wonderful Chair and colleague, Dr Leanna Read, recipient of @UniofAdelaide's Distinguished Alumni Award 2021. Very proud of Leanna and grateful for all she brings to our companies
https://t.co/yQ26vhjiIL
Congratulations to TekCyte’s Research Scientist and T-cell specialist Dr Mona Elsemary who graduated from @UniversitySA with her PhD today. Celebrating here with fellow TekCyte staff @Louise_Biomat and Sameer Al-Bataineh who as UniSA adjunct staff were part of the procession.